This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;14(2):102-3.

doi: 10.1016/S1470-2045(12)70581-8. Epub 2013 Jan 9.

A prognostic model for metastatic renal-cell carcinoma

Matthew D Galsky¹

Affiliations

PMID: 23312462
DOI: 10.1016/S1470-2045(12)70581-8

Comment

A prognostic model for metastatic renal-cell carcinoma

Matthew D Galsky. Lancet Oncol. 2013 Feb.

. 2013 Feb;14(2):102-3.

doi: 10.1016/S1470-2045(12)70581-8. Epub 2013 Jan 9.

Author

Matthew D Galsky¹

Affiliation

¹ Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY 10029, USA. matthew.galsky@mssm.edu

PMID: 23312462
DOI: 10.1016/S1470-2045(12)70581-8

No abstract available

PubMed Disclaimer

Comment on

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan MH, Rha SY, Agarwal N, Kollmannsberger C, Rini BI, Choueiri TK. Heng DY, et al. Lancet Oncol. 2013 Feb;14(2):141-8. doi: 10.1016/S1470-2045(12)70559-4. Epub 2013 Jan 9. Lancet Oncol. 2013. PMID: 23312463 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information